Science Daily: Pharmacology News
APRIL 19, 2024
Analysis of mooring observations and hydrographic data suggest the Atlantic Meridional Overturning Circulation deep water limb in the North Atlantic has weakened. Two decades of continual observations provide a greater understanding of the Earth's climate regulating system.
Drugs.com
APRIL 19, 2024
FRIDAY, April 19, 2024 -- The right diet may be the best medicine for easing the painful symptoms of irritable bowel syndrome (IBS), new research shows. In the study, two different eating plans beat standard medications in treating the debilitating.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BioPharma Drive: Drug Pricing
APRIL 19, 2024
The new label for Alecensa makes it the first targeted treatment available after surgery for people with ALK-positive lung tumors, who are at high risk for brain metastases.
Drugs.com
APRIL 19, 2024
FRIDAY, April 19, 2024 -- An early marker of multiple sclerosis could help doctors figure out who will eventually fall prey to the degenerative nerve disease, a new study says.In one in 10 cases of MS, the body begins producing a distinctive set of.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Collaborative Drug
APRIL 19, 2024
Tokyo, Japan, April 17, 2024 — In a significant move to bolster CDD Vault’s presence in the Japanese market, Collaborative Drug Discovery (CDD) is excited to announce the appointment of Mr. Yasushi Hamagashira as the new Head of Sales and Marketing for Japan. Bringing on board a wealth of experience and expertise, Mr. Hamagashira is set to play a pivotal role in CDD’s strategic expansion and deepening of client engagements in Japan.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Collaborative Drug
APRIL 19, 2024
Celebrating 20 Years of Pioneering Drug Discovery and Collaboration: CDD User Group Meeting
Drugs.com
APRIL 19, 2024
FRIDAY, April 19, 2024 -- The dangerous heart rhythm disorder known as atrial fibrillation is mainly known for increasing people’s risk of stroke.But people with A-Fib actually have a much higher risk of developing heart failure than suffering a.
Collaborative Drug
APRIL 19, 2024
Moderna Embracing Data & AI to Transform Drug Discovery. Are US Scientists Leaving Academia? Can Viagra Support Alzheimer’s Prevention?
Drugs.com
APRIL 19, 2024
FRIDAY, April 19, 2024 -- A head-to-head trial of obese, pre-diabetic people who ate the same amount of daily calories -- with one group following a fasting schedule and the other eating freely -- found no difference in weight loss or other health.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
BioPharma Drive: Drug Pricing
APRIL 19, 2024
The agreement may help Alvotech capitalize on a recent policy shift by CVS that has driven major market share declines for AbbVie’s blockbuster drug.
Drugs.com
APRIL 19, 2024
FRIDAY, April 19, 2024 -- An immune-compromised man with a year-and-a-half-long COVID infection served as a breeding ground for dozens of coronavirus mutations, a new study discovered.
Drug Target Review
APRIL 19, 2024
Can you tell us about your journey in the field of STEM and the challenges you encountered along the way? In the STEM area, I was born as a physicist, which was – among many other things – the inception of looking at the world from many different points of view to get the big picture without losing the fascination with mystery. This eventually translated into looking at my life from many points of view, without fear of change, which opened many opportunities.
Drugs.com
APRIL 19, 2024
FRIDAY, April 19, 2024 -- All expecting mothers should get a blood test for syphilis three times during pregnancy, new guidance issued by the American College of Obstetricians and Gynecologists recommends.The practice advisory calls on doctors to.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
ASPET
APRIL 19, 2024
One cannot survive without regularly urinating and defecating. People with neurological injury (spinal cord injury, traumatic brain injury, stroke) or disease (multiple sclerosis, Parkinson's disease, spina bifida) and many elderly are unable to voluntarily initiate voiding. The great majority of them require bladder catheters to void urine and "manual bowel programs" with digital rectal stimulation and manual extraction to void stool.
Drugs.com
APRIL 19, 2024
FRIDAY, April 19, 2024 -- Black and Hispanic patients with Alzheimer’s disease are greatly underrepresented in clinical trials, even though they’re more likely to get dementia than whites.However, racial discrimination may not be driving this.
Drugs.com
APRIL 19, 2024
FRIDAY, April 19, 2024 -- A British study finds that beyond the physical pain and turmoil of an mpox diagnosis, many of the mostly gay and bisexual men infected during the 2022 outbreak faced stigma, homophobia and shame. Mpox is spread largely.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Agency IQ
APRIL 19, 2024
BY LAURA DIANGELO, MPH On April 14, FDA announced that its Center for Drug Evaluation and Research (CDER) is launching a new clinical trial innovation hub, the CDER Center for Clinical Trial Innovation (C3TI). The announcement includes a scope of projects for the initiative, with a particular focus on pragmatic trial elements, Bayesian analyses and selective safety data collection methods.
Drugs.com
APRIL 19, 2024
MONDAY, April 22, 2024 -- Women who smoke and become pregnant may worry that the weight gain that comes with quitting might bring its own harms to themselves or their baby.However, a new study confirms the health benefits of quitting smoking still.
Drug Patent Watch
APRIL 19, 2024
Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. It is available from one supplier.
Agency IQ
APRIL 19, 2024
BY WALKER LIVINGSTON, ESQ This week, the EPA published an update to its interim guidance on the available disposal and destruction technologies for PFAS-containing materials. This guidance provides valuable insight into the agency’s views on currently available technologies, as well as its plans to evaluate emerging technologies and address existing research gaps.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Drug Patent Watch
APRIL 19, 2024
Annual Drug Patent Expirations for EVRYSDI Evrysdi is a drug marketed by Genentech Inc and is included in one NDA. It is available from one supplier.
Agency IQ
APRIL 19, 2024
BY AMANDA CONTI Last week, FDA’s Oncologic Drugs Advisory Committee (ODAC) voted unanimously in favor of using minimal residual disease (MRD) as an accelerated approval endpoint for multiple myeloma. Committee discussions noted the potential for earlier readout and faster completion of studies, with an expectation that the FDA will ultimately require follow-through with confirmatory trials.
Crucial Data Solutions
APRIL 19, 2024
The landscape of clinical research is undergoing a rapid digital transformation. Data can be collected in ways not imagined just. The post Build Better Studies Faster: 3 Advantages of Mobile eClinical Platforms appeared first on Crucial Data Solutions.
Agency IQ
APRIL 19, 2024
BY KIRSTEN MESSMER, PHD, RAC The EMA has published a draft revision to its 2006 guideline on product development quality considerations for inhaled and nasal products. The revised document contains significant changes that reflect both scientific progress in the field and the experience gained from product applications and scientific advice sessions.
Perficient: Drug Development
APRIL 19, 2024
Total Cost of Ownership (TCO) is a financial estimate that helps consumers and enterprise managers determine direct and indirect costs of a product or system. It goes beyond the initial purchase price to consider other costs involved in procurement, operations, and maintenance over the system’s life. In the B2B market, understanding TCO is crucial as it impacts the return on investment and ultimately the bottom line.
Expert insights. Personalized for you.
322 
Let's personalize your content